Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma.
Vincze B, Kapuvári B, Udvarhelyi N, Horváth Z, Mátrai Z, Czeyda-Pommersheim F, Kőhalmy K, Kovács J, Boldizsár M, Láng I, Kásler M. Vincze B, et al. Among authors: horvath z. Springerplus. 2015 Jul 31;4:387. doi: 10.1186/s40064-015-1171-8. eCollection 2015. Springerplus. 2015. PMID: 26240785 Free PMC article.
[Triple-negative breast carcinoma--rewiev of current literature].
Rubovszky G, Udvarhelyi N, Horváth Z, Láng I, Kásler M. Rubovszky G, et al. Among authors: horvath z. Magy Onkol. 2010 Dec;54(4):325-35. doi: 10.1556/MOnkol.54.2010.4.6. Magy Onkol. 2010. PMID: 21163763 Free article. Review. Hungarian.
Promising novel targeted chemotherapeutic agents include PARP1 inhibitors, a new group of compounds exploiting the defective DNA repair machinery. Rubovszky G, Udvarhelyi N, Horvath Z, Lang I, Kasler M. Triple negative breast carcinoma - rewiev of current literature …
Promising novel targeted chemotherapeutic agents include PARP1 inhibitors, a new group of compounds exploiting the defective DNA repair mach …
[Modern pharmacological therapy of breast cancer].
Láng I, Kahán Z, Hitre E, Dank M, Rubovszky G, Horváth Z, Kásler M. Láng I, et al. Among authors: horvath z. Orv Hetil. 2012 Jan 15;153(2):56-65. doi: 10.1556/OH.2012.29257. Orv Hetil. 2012. PMID: 22217685 Review. Hungarian.
[Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z, Tóth L, Polgár C, Láng I, Gõdény M, Sinkovics I, Horváth Z, Bidlek M, Udvarhelyi N, Bartal A, Sávolt A, Ujhelyi M, Kásler M. Mátrai Z, et al. Among authors: horvath z. Magy Onkol. 2011 Jun;55(2):73-84. Epub 2011 Feb 2. Magy Onkol. 2011. PMID: 21655472 Free article. Review. Hungarian.
[Challenges in oncologic plastic surgery of the breast].
Mátrai Z, Gulyás G, Tóth L, Polgár C, Bidlek M, Szabó E, Láng I, Horváth Z, Udvarhelyi N, Kunos C, Sávolt A, Pesthy P, Kásler M. Mátrai Z, et al. Among authors: horvath z. Magy Onkol. 2011 Mar;55(1):40-52. Epub 2011 Mar 31. Magy Onkol. 2011. PMID: 21617790 Free article. Review. Hungarian.
Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological response.
Horváth Z, Torday L, Hitre E, Ganofszky E, Juhos E, Czeglédi F, Urbán L, Polgár C, Láng I, Eckhardt S, Kásler M. Horváth Z, et al. Pathol Oncol Res. 2011 Sep;17(3):541-50. doi: 10.1007/s12253-010-9344-9. Epub 2010 Dec 14. Pathol Oncol Res. 2011. PMID: 21153723 Free article.
457 results